4Tassopoulos NC;Volpes R;Pastore G.Efficacy of lamivudine in patients with hepatitis B e antigen-negative hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B[J],1999(29).
5Hunt CM;McGill JM;Allen MI.Clinical relevance of hepatitis B viral mutations[J],2000(5).
6Liaw YF;Chien RN;Yeh CT.Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy[J],1999(2).
7Conjeevaram HS;Lok AS.Management of chronic hepatitis B[J],2003(zk).
8Gandhi MJ;Yang GG;McMahon BJ.Hepatitis B virions isolated with antibodies to the pre-S1 domain reveal occult viremia by PCR in Alaska Native HBV carriers who have seroconverted[J],2000.
9Adachi H;Kaneko S;Matsushita E.Clearance of HBsAg in seven patients with chronic hepatitis B[J],1992.
10Locarnini S;Birch C.Antiviral chemotherapy for chronic hepatitis B infection:lessons learned from treating HIV-infected patients[J],1999.
